OncoImmunology
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
OncoImmunology
ONCOIMMUNOLOGY
ISSN / eISSN
2162-4011 / 2162-402X
Aims and Scope
Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. We now create a new, high-profile journal, OncoImmunology, that specifically deals with tumor immunology. Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies. There is also an ever growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors. To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands. As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies.
OncoImmunology will accept high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses will be welcome.
OncoImmunology will accept high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses will be welcome.
Subject Area
IMMUNOLOGY
ONCOLOGY
CiteScore
12.50
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Oncology | Q1 | #37/366 |
| Medicine - Immunology and Allergy | Q1 | #27/211 |
| Medicine - Immunology | Q1 | #31/217 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| IMMUNOLOGY - SCIE | Q1 |
| ONCOLOGY - SCIE | Q1 |
H-index
49
Country/Area of Publication
UNITED STATES
Publisher
Landes Bioscience
Annual Article Volume
174
Open Access
NO
Contact
530 WALNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search